Dissecting the mechanism of T-cell anergy with immunophilin ligands

Jonathan Powell, Yan Zheng

Research output: Contribution to journalArticle

Abstract

T-cell receptor engagement in the absence of costimulation leads to T-cell anergy. The biochemical and molecular mechanisms responsible for this form of T-cell tolerance are becoming better defined. This review examines the intersection between T-cell receptor-induced anergy and the immunophilin ligands ciclosporin A, FK-506, rapamycin and sanglifehrin A, and focuses on how these compounds play an important role in dissecting the pathways leading to the induction and maintenance of anergy. Finally, the clinical role of these compounds as immunosuppressive agents will be discussed in the context of their effects on promoting or inhibiting T-cell anergy.

Original languageEnglish (US)
Pages (from-to)1002-1007
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Volume7
Issue number11
StatePublished - Nov 2006

Fingerprint

Immunophilins
T-Cell Antigen Receptor
Ligands
T-Lymphocytes
Tacrolimus
Sirolimus
Immunosuppressive Agents
Cyclosporine
Maintenance

Keywords

  • Anergy
  • Ciclosporin A
  • FK-506
  • Immunophilin
  • Mammalian target of rapamycin
  • Rapamycin
  • Sanglifehrin A
  • T-cell

ASJC Scopus subject areas

  • Pharmacology

Cite this

Dissecting the mechanism of T-cell anergy with immunophilin ligands. / Powell, Jonathan; Zheng, Yan.

In: Current Opinion in Investigational Drugs, Vol. 7, No. 11, 11.2006, p. 1002-1007.

Research output: Contribution to journalArticle

@article{1a851571e50647cca574767bf2aec434,
title = "Dissecting the mechanism of T-cell anergy with immunophilin ligands",
abstract = "T-cell receptor engagement in the absence of costimulation leads to T-cell anergy. The biochemical and molecular mechanisms responsible for this form of T-cell tolerance are becoming better defined. This review examines the intersection between T-cell receptor-induced anergy and the immunophilin ligands ciclosporin A, FK-506, rapamycin and sanglifehrin A, and focuses on how these compounds play an important role in dissecting the pathways leading to the induction and maintenance of anergy. Finally, the clinical role of these compounds as immunosuppressive agents will be discussed in the context of their effects on promoting or inhibiting T-cell anergy.",
keywords = "Anergy, Ciclosporin A, FK-506, Immunophilin, Mammalian target of rapamycin, Rapamycin, Sanglifehrin A, T-cell",
author = "Jonathan Powell and Yan Zheng",
year = "2006",
month = "11",
language = "English (US)",
volume = "7",
pages = "1002--1007",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "11",

}

TY - JOUR

T1 - Dissecting the mechanism of T-cell anergy with immunophilin ligands

AU - Powell, Jonathan

AU - Zheng, Yan

PY - 2006/11

Y1 - 2006/11

N2 - T-cell receptor engagement in the absence of costimulation leads to T-cell anergy. The biochemical and molecular mechanisms responsible for this form of T-cell tolerance are becoming better defined. This review examines the intersection between T-cell receptor-induced anergy and the immunophilin ligands ciclosporin A, FK-506, rapamycin and sanglifehrin A, and focuses on how these compounds play an important role in dissecting the pathways leading to the induction and maintenance of anergy. Finally, the clinical role of these compounds as immunosuppressive agents will be discussed in the context of their effects on promoting or inhibiting T-cell anergy.

AB - T-cell receptor engagement in the absence of costimulation leads to T-cell anergy. The biochemical and molecular mechanisms responsible for this form of T-cell tolerance are becoming better defined. This review examines the intersection between T-cell receptor-induced anergy and the immunophilin ligands ciclosporin A, FK-506, rapamycin and sanglifehrin A, and focuses on how these compounds play an important role in dissecting the pathways leading to the induction and maintenance of anergy. Finally, the clinical role of these compounds as immunosuppressive agents will be discussed in the context of their effects on promoting or inhibiting T-cell anergy.

KW - Anergy

KW - Ciclosporin A

KW - FK-506

KW - Immunophilin

KW - Mammalian target of rapamycin

KW - Rapamycin

KW - Sanglifehrin A

KW - T-cell

UR - http://www.scopus.com/inward/record.url?scp=33751029468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751029468&partnerID=8YFLogxK

M3 - Article

C2 - 17117589

AN - SCOPUS:33751029468

VL - 7

SP - 1002

EP - 1007

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 11

ER -